Tourmaline Bio Investor Relations Material
Latest events
Investor Day 2024
Tourmaline Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tourmaline Bio Inc
Access all reports
Tourmaline Bio Inc. is a biotechnology company focused on developing treatments for immune and inflammatory diseases. The company is engaged in the late-stage clinical development of therapies aimed at significantly improving the lives of patients with severe autoimmune and inflammatory conditions. Its product pipeline includes medicines designed to address conditions such as atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company is headquartered in New York, NY, and its shares are listed on the NASDAQ.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
TRML
Country
🇺🇸 United States